ALKS vs GS · P/E 14, rev $1.56B vs P/E 20, $324.25B cap
Alkermes Plc (ALKS) versus Goldman Sachs Group Inc (GS) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
GS does not have a complete income-statement cache yet.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. GS currently screens at market cap $324.25B and trailing P/E 20.1.
Not investment advice. Open the ALKS and GS stock pages for the full models.
Not investment advice.